Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc.（PCSA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PCSA · 截至 2026年6月9日
活动摘要
买入笔数
23
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Processa Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PCSA 季度内部人买卖趋势
PCSA 内幕交易卖出 · PCSA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · PCSA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PCSA 高管卖出股份 · PCSA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 29, 2026 | Young David Pres. Research & Development · Director | Purchase | 1,786 | $5K | Form 4 |
| May 29, 2026 | SKIBSTED RUSSELL CFO | Purchase | 2,292 | $6K | Form 4 |
| May 29, 2026 | Ng George K CEO · Director | Purchase | 2,129 | $5K | Form 4 |
| May 29, 2026 | Lin Patrick Chief Business - Strategy Off | Purchase | 1,582 | $4K | Form 4 |
| May 29, 2026 | Guy Wendy Chief Administrative Officer | Purchase | 1,829 | $5K | Form 4 |
| May 15, 2026 | Ng George K CEO · Director | Purchase | 1,843 | $5K | Form 4 |
| May 15, 2026 | Young David Pres. Research & Development · Director | Purchase | 1,545 | $5K | Form 4 |
| May 15, 2026 | Lin Patrick Chief Business - Strategy Off | Purchase | 1,369 | $4K | Form 4 |
| May 15, 2026 | Guy Wendy Chief Administrative Officer | Purchase | 1,583 | $5K | Form 4 |
| May 15, 2026 | SKIBSTED RUSSELL CFO | Purchase | 1,984 | $6K | Form 4 |
| Apr 30, 2026 | Young David Pres. Research & Development · Director | Purchase | 1,706 | $5K | Form 4 |
| Apr 30, 2026 | SKIBSTED RUSSELL CFO | Purchase | 2,190 | $6K | Form 4 |
| Apr 30, 2026 | Ng George K CEO · Director | Purchase | 2,034 | $5K | Form 4 |
| Apr 30, 2026 | Lin Patrick Chief Business - Strategy Off | Purchase | 1,511 | $4K | Form 4 |
| Apr 30, 2026 | Guy Wendy Chief Administrative Officer | Purchase | 1,748 | $5K | Form 4 |
| Apr 30, 2026 | Bigora Sian Chief Development Officer | Purchase | 1,986 | $5K | Form 4 |
| Apr 15, 2026 | Young David Pres. Research & Development · Director | Purchase | 1,545 | $5K | Form 4 |
| Apr 15, 2026 | Ng George K CEO · Director | Purchase | 1,843 | $5K | Form 4 |
| Apr 15, 2026 | Lin Patrick Chief Business - Strategy Off | Purchase | 1,369 | $4K | Form 4 |
| Apr 15, 2026 | Guy Wendy Chief Administrative Officer | Purchase | 1,583 | $5K | Form 4 |
| Apr 15, 2026 | Bigora Sian Chief Development Officer | Purchase | 1,799 | $5K | Form 4 |
| Apr 15, 2026 | SKIBSTED RUSSELL CFO | Purchase | 1,984 | $6K | Form 4 |
| Mar 31, 2026 | Neal James R Director | Purchase | 789 | $2K | Form 4 |
| Mar 31, 2026 | Young David Pres. Research & Development · Director | Purchase | 1,810 | $5K | Form 4 |
| Mar 31, 2026 | SKIBSTED RUSSELL CFO | Purchase | 2,324 | $6K | Form 4 |
Young David
Pres. Research & Development · Director
日期
May 29
股数
1,786
均价
$2.57
总金额
$5K
Young David
Pres. Research & Development · Director
日期
May 15
股数
1,545
均价
$2.97
总金额
$5K
Young David
Pres. Research & Development · Director
日期
Apr 30
股数
1,706
均价
$2.69
总金额
$5K
Young David
Pres. Research & Development · Director
日期
Apr 15
股数
1,545
均价
$2.97
总金额
$5K
Young David
Pres. Research & Development · Director
日期
Mar 31
股数
1,810
均价
$2.54
总金额
$5K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PCSA 内幕交易
PCSA 内幕交易
Processa Pharmaceuticals, Inc.（PCSA）内幕交易数据来源于公司内部人（包括Lin Patrick (Chief Business - Strategy Off), Young David (Pres. Research & Development · Director), Guy Wendy (Chief Administrative Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PCSA内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Processa Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PCSA 内幕交易 · 5个问题Processa Pharmaceuticals, Inc.（PCSA）的内部人包括高管和董事，如Lin Patrick (Chief Business - Strategy Off), Young David (Pres. Research & Development · Director), Guy Wendy (Chief Administrative Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026